Today: 25 April 2026
Subscribe
Browse Category

NASDAQ:CNC 6 February 2026

Centene stock slides as 2026 profit view beats estimates but revenue forecast falls short

Centene stock slides as 2026 profit view beats estimates but revenue forecast falls short

Centene shares fell 5.7% to $37.64 after the company forecast 2026 adjusted profit above $3 per share but projected revenue below Wall Street estimates. Molina Healthcare dropped about 28%, weighing on the sector. Centene reported a fourth-quarter adjusted loss of $1.19 per share and a health benefits ratio of 94.3%. The company set its next earnings update for April 28.
6 February 2026
··

Stock Market Today

  • TSX Stock Poised for 22% Upside as Alternative Energy Gains Amid U.S.-Israel-Iran Conflict
    April 24, 2026, 6:03 PM EDT. David Rosenberg of Rosenberg Research highlights a rebound in alternative energy stocks due to the U.S.-Israel-Iran tensions. The conflict reinforces energy security as a crucial priority, easing negative sentiment around clean energy. Investors are advised to manage geopolitical risks within portfolios rather than making hasty trades. Opportunities span beyond energy generation to batteries, grid modernization, and energy storage. Commodities linked to renewables include copper, uranium, lithium, nickel, and rare earth metals. Rosenberg recommends ETFs such as IBAT, ICLN, COPX, BASE, CPCC, REMX, and URA for exposure. The iShares Global Clean Energy ETF (ICLN) has surged nearly 10% since the conflict began. These developments present renewable energy not only as a growth area but also as a diversifier and hedge for investors.

Latest article

Magnachip Semiconductor Stock Jumps 23% as New BatteryFET Puts Q1 Earnings in Focus

Magnachip Semiconductor Stock Jumps 23% as New BatteryFET Puts Q1 Earnings in Focus

24 April 2026
Magnachip Semiconductor’s U.S.-listed shares jumped 23% late Friday to $5.25 ahead of its April 28 earnings report. The company this week launched two 8th-generation 12V MOSFETs for smartphone battery protection, with one already in mass production for a major global smartphone maker. Magnachip has guided for Q1 revenue of $44–$48 million and a gross margin of 14–16%. Analysts expect a loss of 22 cents per share.
HCA Healthcare Stock Drops Despite Profit Beat As Weak Volumes Rattle Investors

HCA Healthcare Stock Drops Despite Profit Beat As Weak Volumes Rattle Investors

24 April 2026
HCA Healthcare shares dropped 8.8% to $432.46 after first-quarter profit narrowly beat estimates but showed weaker patient volumes and payer-mix concerns. Revenue rose 4.3% to $19.1 billion, net income hit $1.62 billion, and adjusted EBITDA climbed 1.9% to $3.8 billion. Respiratory admissions fell 42% year-over-year. HCA reaffirmed its 2026 financial guidance.
Go toTop